Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.67B | $2.71B | $2.51B | $3.17B | $4.03B | $32.00B | $3.78B | $3.14B |
| Cost of revenue | $722.0M | $726.5M | $631.6M | $800.0M | $1.03B | $7.95B | $946.3M | $869.2M |
| Gross profit | $1.95B | $1.99B | $1.88B | $2.37B | $3.00B | $24.04B | $2.83B | $2.27B |
| Gross margin | 73.0% | 73.2% | 74.9% | 74.8% | 74.4% | 75.1% | 75.0% | 72.3% |
| R&D | $133.3M | $103.0M | $94.3M | $112.7M | $117.5M | $782.5M | $100.5M | $103.1M |
| Operating income | $515.9M | $473.8M | $399.5M | $525.7M | $727.8M | $6.91B | $842.6M | $717.8M |
| EBITDA | $738.5M | $527.3M | $435.8M | $772.3M | $995.9M | $8.87B | $1.22B | $1.35B |
| Net income | $526.2M | $504.6M | $279.0M | $556.7M | $737.2M | $971.6M | $840.1M | $949.9M |
| Net margin | 19.7% | 18.6% | 11.1% | 17.6% | 18.3% | 3.0% | 22.2% | 30.3% |
| EPS (diluted) | 0.64 | 0.65 | 0.37 | 0.74 | 0.96 | 1.28 | 1.11 | 1.26 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.0B | $1.09 | $1.09–$1.09 | 1 |
| 2027 | $3.3B | $1.22 | $1.22–$1.22 | 1 |
Forward consensus · source: Financial Modeling Prep
CHINA SHINEWAY PHARM GRP
No one on the platform currently holds CSWYF.
No tracked institution reports a position in CSWYF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-06 | $0.4870 | 2026-05-19 |
| 2025-09-11 | $0.1200 | 2025-09-26 |
| 2025-05-06 | $0.3850 | 2025-05-20 |
| 2024-09-12 | $0.1200 | 2024-09-27 |
| 2024-05-01 | $0.4610 | 2024-05-17 |
| 2023-09-13 | $0.1180 | 2023-09-29 |
No one on the platform has traded CSWYF yet.
| +0.00% |
| $499M |
| — |
| KDGTFKindstar Globalgene Technology, Inc. | $0.68 | +0.00% | $675M | — |
| KKPCFKaken Pharmaceutical Co., Ltd. | $26.00 | +0.00% | $985M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.